Cargando…

Clinical and Ultrasonographic Profile of Adalimumab-treated Hidradenitis Suppurativa Patients: A Real-life Monocentric Experience

Ultrasonography has proven useful for diagnosis and treatment monitoring in patients with hidradenitis suppurativa. The aim of this study was to assess the clinical response to adalimumab using ultrasound findings. This prospective study collected data on demographic features, disease severity, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	CHIRICOZZI, Andrea, GIOVANARDI, Giulia, GARCOVICH, Simone, MALVASO, Dalma, CALDAROLA, Giacomo, FOSSATI, Barbara, GUERRIERO, Cristina, DE SIMONE, Clara, PERIS, Ketty
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2020
Materias:	Clinical Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175054/ https://www.ncbi.nlm.nih.gov/pubmed/32421198 http://dx.doi.org/10.2340/00015555-3520

Ejemplares similares

Apremilast for the treatment of hidradenitis suppurativa associated with psoriatic arthritis in multimorbid patients: Case report and review of literature
por: Garcovich, Simone, et al.
Publicado: (2020)

Prevalence of Neuropathic Pain and Related Characteristics in Hidradenitis Suppurativa: A Cross-Sectional Study
por: Garcovich, Simone, et al.
Publicado: (2020)

IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa
por: Malvaso, Dalma, et al.
Publicado: (2023)

Similar Levels of Efficacy of Two Different Maintenance Doses of Adalimumab on Clinical Severity and Quality of Life of Patients with Hidradenitis Suppurativa
por: Fania, Luca, et al.
Publicado: (2022)

Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study
por: Burlando, Martina, et al.
Publicado: (2022)

Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021)

Successful Treatment of Recalcitrant Hidradenitis Suppurativa with Adalimumab
por: Gorovoy, Ian, et al.
Publicado: (2009)

Novel nicastrin mutation in hidradenitis suppurativa–Dowling–Degos disease clinical phenotype: more than just clinical overlap?
por: Garcovich, S., et al.
Publicado: (2020)

Genital lymphedema associated with hidradenitis suppurativa unresponsive to adalimumab treatment
por: Musumeci, Maria Letizia, et al.
Publicado: (2019)

Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost‐effectiveness?
por: Roccuzzo, Gabriele, et al.
Publicado: (2022)

Two Cases of Paradoxical Hidradenitis Suppurativa while on Adalimumab
por: Harvin, Glenn, et al.
Publicado: (2016)

Treatment of Hidradenitis Suppurativa Patient with Klinefelter Syndrome by Adalimumab
por: Shin, Ji Yeoun, et al.
Publicado: (2019)

Adalimumab-Induced Thrombocytopenia in a Patient With Hidradenitis Suppurativa
por: Al-Tkrit, Amna, et al.
Publicado: (2021)

ALK+ ALCL in the setting of adalimumab‐related hidradenitis suppurativa
por: Craig, Alexander, et al.
Publicado: (2023)

Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data
por: Kyriakou, Aikaterini, et al.
Publicado: (2018)

Real-world drug survival of patients with hidradenitis suppurativa treated with adalimumab
por: Saal, Ryan C., et al.
Publicado: (2023)

Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
por: Fotiadou, Christina, et al.
Publicado: (2016)

A complication in a patient with hidradenitis suppurativa taking adalimumab
por: Perez, Olivia D., et al.
Publicado: (2022)

Optic neuropathy in a patient treated with adalimumab for hidradenitis suppurativa
por: Alnaif, Sarah, et al.
Publicado: (2023)

Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa—A Monocentric Study in Germany
por: Abu Rached, Nessr, et al.
Publicado: (2023)

Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab
por: Bosnić, Dubravka, et al.
Publicado: (2016)

The Impact of Body Mass Index Upon the Efficacy of Adalimumab in Hidradenitis Suppurativa
por: Frew, John W., et al.
Publicado: (2021)

Paradoxical Reaction in a Patient with Hidradenitis Suppurativa Undergoing Adalimumab Treatment
por: IKEYA, Soichiro, et al.
Publicado: (2021)

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
por: Martora, Fabrizio, et al.
Publicado: (2023)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
por: Chiricozzi, Andrea, et al.
Publicado: (2019)

Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study
por: Pirro, Federico, et al.
Publicado: (2021)

Potential role of serum amyloid A in hidradenitis suppurativa
por: Iannone, Michela, et al.
Publicado: (2019)

Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs
por: Burzi, Lorenza, et al.
Publicado: (2022)

Metastatic squamous cell carcinoma in a patient treated with adalimumab for hidradenitis suppurativa
por: Giesey, Rachel, et al.
Publicado: (2017)

Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020)

Treatment of lichen planopilaris with adalimumab in a patient with hidradenitis suppurativa and rheumatoid arthritis
por: Alam, Maryam Shayesteh, et al.
Publicado: (2020)

Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
por: Blaszczak, Alecia, et al.
Publicado: (2020)

Switching from Adalimumab Originator to Biosimilar: Clinical Experience in Patients with Hidradenitis Suppurativa
por: Montero-Vilchez, Trinidad, et al.
Publicado: (2022)

Adalimumab Effect on Pain in Hidradenitis Suppurativa Patients: Systematic Review and Meta-Analysis
por: Tsentemeidou, Aikaterini, et al.
Publicado: (2022)

Adalimumab for the Treatment of Periodontitis in a 35-Year-Old Woman with Hidradenitis Suppurativa
por: Yao, Yiqiu, et al.
Publicado: (2023)

Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections
por: Crowley, Erika L, et al.
Publicado: (2018)

Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2020)

Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study
por: Prens, L.M., et al.
Publicado: (2021)

Adalimumab therapy is associated with increased faecal short chain fatty acids in hidradenitis suppurativa
por: Tatian, Artiene, et al.
Publicado: (2022)

Real‐world effectiveness of adalimumab in patients with moderate‐to‐severe hidradenitis suppurativa: the 1‐year SOLACE study
por: Gulliver, W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rlkom3bepiag8s76ipis4qmb91